奈比洛尔加西地那非治疗pde5抑制剂无反应的高血压患者

{"title":"奈比洛尔加西地那非治疗pde5抑制剂无反应的高血压患者","authors":"A. Khelaia","doi":"10.1016/s1569-9056(19)35031-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12149,"journal":{"name":"European Urology Supplements","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nebivolol plus sildenafil in PDE 5 inhibitors non-responder men with arterial hypertension\",\"authors\":\"A. Khelaia\",\"doi\":\"10.1016/s1569-9056(19)35031-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12149,\"journal\":{\"name\":\"European Urology Supplements\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Urology Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s1569-9056(19)35031-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Urology Supplements","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1569-9056(19)35031-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}